572 related articles for article (PubMed ID: 14965321)
21. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs.
Giuliano F; Warner TD
Br J Pharmacol; 1999 Apr; 126(8):1824-30. PubMed ID: 10372826
[TBL] [Abstract][Full Text] [Related]
22. Closing in on a stomach-sparing aspirin substitute.
Service RF
Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
[No Abstract] [Full Text] [Related]
23. Cyclooxygenase 2 inhibitors: discovery, selectivity and the future.
Marnett LJ; Kalgutkar AS
Trends Pharmacol Sci; 1999 Nov; 20(11):465-9. PubMed ID: 10542447
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a new class of selective cyclooxygenase-2 (COX-2) inhibitor that covalently modifies the isozyme.
Kalgutkar AS; Crews BC; Rowlinson SW; Garner C; Marnett LJ
Adv Exp Med Biol; 1999; 469():139-43. PubMed ID: 10667322
[No Abstract] [Full Text] [Related]
25. Cyclooxygenase-2 biology.
ClĂ ria J
Curr Pharm Des; 2003; 9(27):2177-90. PubMed ID: 14529398
[TBL] [Abstract][Full Text] [Related]
26. The cyclooxygenase-2 structure: new drugs for an old target?
Garavito RM
Nat Struct Biol; 1996 Nov; 3(11):897-901. PubMed ID: 8901861
[No Abstract] [Full Text] [Related]
27. The development of COX2 inhibitors.
Flower RJ
Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
[TBL] [Abstract][Full Text] [Related]
28. The structures of prostaglandin endoperoxide H synthases-1 and -2.
Garavito RM; Malkowski MG; DeWitt DL
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():129-52. PubMed ID: 12432914
[TBL] [Abstract][Full Text] [Related]
29. Differential binding mode of diverse cyclooxygenase inhibitors.
Llorens O; Perez JJ; Palomer A; Mauleon D
J Mol Graph Model; 2002 Mar; 20(5):359-71. PubMed ID: 11885959
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of action of aspirin.
Vane JR; Botting RM
Thromb Res; 2003 Jun; 110(5-6):255-8. PubMed ID: 14592543
[TBL] [Abstract][Full Text] [Related]
31. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.
Wallace JL; Bak A; McKnight W; Asfaha S; Sharkey KA; MacNaughton WK
Gastroenterology; 1998 Jul; 115(1):101-9. PubMed ID: 9649464
[TBL] [Abstract][Full Text] [Related]
33. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
34. Dual COX inhibition and upper gastrointestinal damage.
Skelly MM; Hawkey CJ
Curr Pharm Des; 2003; 9(27):2191-5. PubMed ID: 14529399
[TBL] [Abstract][Full Text] [Related]
35. COX-2 inhibitors.
Hawkey CJ
Lancet; 1999 Jan; 353(9149):307-14. PubMed ID: 9929039
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
Famaey JP
Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).
Taketo MM
J Natl Cancer Inst; 1998 Nov; 90(21):1609-20. PubMed ID: 9811310
[TBL] [Abstract][Full Text] [Related]
38. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
Kalgutkar AS; Kozak KR; Crews BC; Hochgesang GP; Marnett LJ
J Med Chem; 1998 Nov; 41(24):4800-18. PubMed ID: 9822550
[TBL] [Abstract][Full Text] [Related]
39. Variants of cyclooxygenase-1 and their roles in medicine.
Simmons DL
Thromb Res; 2003 Jun; 110(5-6):265-8. PubMed ID: 14592545
[TBL] [Abstract][Full Text] [Related]
40. [Coxibs: cyclooxygenase-2 inhibitors].
Turnheim K
Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]